HIVWomen
Meeting category
Date(s)
12 Apr 2024 - 13 Apr 2024
Location
Washington D.C., United States
Meeting type
Hybrid Meeting
Organizer
Titanium Level Sponsor
Sponsor logos
NIH 2023

International Workshop on HIV & Women 2024

General
About this Program
Group photo - HIV & Women 2024

The 14th International Workshop on HIV & Women took place in a hybrid format on 12 -13 April 2024 in Washington D.C., United States.

The International Workshop on HIV & Women has now completed its 13th year and continues to evolve. It is an outstanding opportunity for healthcare providers, researchers, government, industry, and community representatives to discuss, debate, and further their knowledge on the issues related to HIV and women.

The format of the workshop enables attendees to learn from world-leading HIV experts and discuss the issues, gaps, and opportunities for further learning and research. Many of the attendees continue to participate each year and have formed valuable relationships and partnerships that have led to collaborative projects.

The enthusiasm and dedication of the participants is palpable throughout the workshop. The debates and roundtables are an important vehicle to discuss the issues and challenge dogmas.

Over the years, the number and quality of submitted abstracts have continued to improve. The workshop also provides a forum for early-career investigators to present their work and to personally meet with experts they view as mentors and inspirations for their work. The workshop considers both local and global issues and the information learnt in one setting is often translated into another.

We encourage you to consider joining us in 2024! 

On behalf of the Organizing Committee,

Workshop Chair
General Information 
Entry Requirements
Before your travel to the United States, we advise you to check the entry and visa requirements. You can find more information here: https://travel.state.gov/content/travel/en/us-visas.html
Uniques Features
- Two-day hybrid meeting
- Invited lectures from international experts
- Interactive roundtable sessions
- Ample time for discussion
Who Should Attend?
- HIV clinicians
- Researchers
- OBGYNs
- Government and NGO representatives
- Industry representatives
- Community advocates
- Pharmacists
- Medical Students
- Other healthcare providers involved in daily care of women living with HIV
Meeting Objectives
This meeting aims to:

- Facilitate an unbiased and scientific knowledge exchange regarding HIV & Women, and encourage early-career investigators to actively partake in the workshop;

- Summarize and promote the current state of the science regarding HIV & Women, and its successful translation and dissemination; and

- Foster new and lasting cross-disciplinary partnerships and collaborations between researchers and women to improve knowledge sharing, with the end goal of improving the quality of life of women living with HIV.
Learning Objectives
After participating in this activity, participants will be able to:

- Outline the disruptions that global crises brought to HIV service delivery;
- Describe the multiple facets of weight gain and metabolic complications following ART initiation;
- Discuss the updated guidelines for breastfeeding;
- Specify new treatments and prevention regimens for women living with HIV;
- Understand the interplay between HIV and comorbidities in aging women living with HIV.
Practical Information 
Venue
HIV & Women 2024 will take place at the The Mayflower Hotel: 1127 Connecticut Ave NW, Washington, DC 20036, United States
Accommodation
More information on accommodation can be found on the accommodation tab of the website.
Entry Requirements
All travelers arriving to the United States, are required to apply for a VISA or an Electronic System for Travel Authorisation (ESTA). To find out which one applies to you, please visit the US State Department Website: https://travel.state.gov/content/travel/en/us-visas/visa-information-resources/wizard.html
Badges
All participants are requested to wear the badge at all times during the workshop to ensure admission to the meeting.
Certificate of Attendance
A certificate of attendance will be sent to participants after they successfully complete the program and post-meeting survey.
Language
The official language of the workshop is English.
Translation will not be provided.
Enduring Materials
Enduring materials will be available shortly after the conclusion of the workshop.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and Insurance
By registering for the workshop, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Program

Download Program

Download Program Book

Download Abstract Book

The program is currently under development and subject to change.

The below times are set in Eastern Daylight Time. Please, use this tool to convert the timing into your time zone.

Friday, 12 April
Opening of the Workshop - 08:30
08:30
Opening Words
Sharon Walmsley, CM, MD, FRCPC
University Health Network, Canada
Angelina Namiba, BA Hons
4MNetwork of Mentor Mothers, United Kingdom
Session 1: Increasing the Burden: Impact of Global Crises on Women Living with HIV -
Chairs
Sharon Walmsley, CM, MD, FRCPC
University Health Network, Canada
Angelina Namiba, BA Hons
4MNetwork of Mentor Mothers, United Kingdom
08:45
Overview of the Impact of the Global Climate Change Crisis on Infectious Diseases
Siegbert Rieg, MD
University Medical Center Freiburg, Germany
09:05
Refugees/Women Living with HIV on the Move - Implications for Management
Chioma Nnaji, MEd, MPH
Multicultural AIDS Coalition (MAC), United States
09:25
Q&A
Session 2: Debate: ART Causes Hypertension in HIV -
Chairs
Catherine Hankins, MD, PhD, FRCPC, CM
McGill University, Canada
9:40
Opening Words
9:50
Voting
9:55
Healthcare Provider: For the Proposition
Claudia Cortes, MD
University of Chile, Chile
10:02
Healthcare Provider: Against the Proposition
Jürgen Rockstroh, MD
University of Bonn, Germany
10:09
Community Representative: For the Proposition
Angelina Namiba, BA Hons
4MNetwork of Mentor Mothers, United Kingdom
10:16
Community Representative: Against the Proposition
Lucy Hutchinson
The Sussex Beacon, United Kingdom
10:23
Discussion with the Audience
10:30
Rebuttal
10:34
Voting
10:39
Results & Closing
10:45
Coffee Break
NIH/OAR Supported Symposium: Breaking the Barriers to the Prevention and Treatment of HIV among Women - 11:15
11:15
Opening & Welcome
Natella Rakhmanina, MD, PhD, FAAP, FCP, AAHIVS
Children’s National Hospital, United States
Kathleen Powis, MD
Harvard Medical School / Massachusetts General Hospital, United States
Mary Glenshaw, PhD, MPH
NIH Office of AIDS Research (OAR), United States
11:25
Avoiding Body Weight Bias in Healthcare for Women with HIV
Julie Schexnayder
University of Alabama at Birmingham, United States
11:35
Response
Amanda Willig, PhD, RD
University of Alabama at Birmingham, United States
11:40
Q&A
11:45
HIV, PrEP Use and Related Biases among Adolescent Girls and Young Women in South Africa
Krishnaveni Surina Reddy, MMedSci
Wits Reproductive Health and HIV Institute (Wits RHI), South Africa
11:55
Response
Christina Psaros, PhD
Harvard Medical School / Massachusetts General Hospital, United States
12:00
Q&A
12:05
PrEP Equity for Black Women - A "Dream Deferred” Becoming Reality
Latesha Elopre, MD, MSPH
University of Alabama at Birmingham, United States
12:15
Response
Abby Charles, MPH
Institute for Public Health Innovation (IPHI), United States
12:20
Q&A
12:25
Closing
Natella Rakhmanina, MD, PhD, FAAP, FCP, AAHIVS
Children’s National Hospital, United States
12:30
End of Symposium
12:30
Lunch Break
Session 3: HIV and Co-Infections -
Chairs
Deborah Money, MD, FRCSC
University of British Columbia, Canada
Natella Rakhmanina, MD, PhD, FAAP, FCP, AAHIVS
Children’s National Hospital, United States
13:30
HIV and TB
Judith Kose, MD, PhD
Africa CDC, Eastern Africa Regional Coordinating Centre, Kenya
13:50
HPV and Cervical/Anal Cancer in Women with HIV
Deborah Money, MD, FRCSC
University of British Columbia, Canada
14:10
HIV and Long COVID
Simiso Sokhela, BSc, MBChB, Dip HIV Man
Ezintsha, University of the Witwatersrand, South Africa
14:30
#1 - Dynamic Interplay of High-Risk Human Papillomavirus in Women Living with HIV: Persistence, Clearance, Incidence and Synergies with Human T-lymphotropic Virus-1
James Kangethe
Kenya
14:45
#2 - Seroprevalence and Correlates of Co-infection With HIV and Active Syphilis Among Women in Six Sub-Saharan African Countries: Results From Population-Based HIV Impact Assessments (PHIAs)
Derrick Bary Abila
Uganda
15:00
#3 - Roll Out of Cervical Cancer Screening and Treatment Program; The Uganda’s Success Story
Josephine Ninsiima
Uganda
15:15
Q&A
15:30
Coffee Break
Industry Supported Symposium: People First Language - Why it Matters - 16:00
16:00
Introduction
Ama Appiah, BSc, MRPharmS
ViiV Healthcare, United Kingdom
16:05
What Is People-First Language, Why Does It Matter, and What Does It Mean for the HIV Community?
Yvonne Gilleece, MB, BCh, BAO
Brighton & Sussex Medical School and University Hospitals Sussex NHS Foundation Trust, United Kingdom
Angelina Namiba, BA Hons
4MNetwork of Mentor Mothers, United Kingdom
Marvelous Muchenje, BSW, MSc, PhD
ViiV Healthcare, Canada
16:30
Panel Discussion and Q&A
16:40
Call to Action and Close
16:45
End of the Symposium
Welcome Reception & Guided Poster Tours (3 Parallel Sessions) -
Guided Poster Tour 1: Reaching Out
Moderator: Lena Serghides, PhD
University Health Network, Canada
#14 - Flourishing With HIV: A Roadmap for Women and Girls
Ciarra Covin, United States
#15 - Clinic-Based HIV Identification and Prevention in Cisgender Women Using Electronic Resources (CHIPPER): A Hybrid Type II Implementation/Effectiveness Trial
Crystal Christie, United States
#16 - Co-designing a Peer-Led Mhealth Intervention (“TwySHE”) to Prevent HIV and Unintended Pregnancy Among Female Students in Zambia: Findings From Participatory Human Centered Design Workshops
Karen Hampanda, United States
Guided Poster Tour 2: EMPOWER
Moderator: Mona Loufty, MD, FRCPC, MPH
Women's College Research Institute (Univ. Toronto), Canada
#20 - Exploring Trauma Healing Preferences: Findings from the Trauma- and Violence-Aware Care (TVAC) Mixed Methods Survey
Logan Kennedy, Canada
#22 - Influences of Gender-Based Stigma on HIV Prevention and Care among Older Women
Thi Vu, United States
#45 - PrEP Uptake in Cisgender Females at Risk for HIV in South Florida
Jennifer Kuretski, United States
# 47 - State-Level Barriers and Facilitators for Implementing PrEP Services in Title X Family Planning Clinics
Madelyn Carlson, United States
#70 - Awareness and Acceptability of HIV Pre-exposure Prophylaxis among HIV-Negative Pregnant and Breastfeeding Women in Zambia: Analysis of ZAMPHIA 2021
Wantula Sichembe, Zambia
Guided Poster Tour 3: ART Treatment and Care
Moderator: William R. Short, MD, MPH, FIDSA
University of Pennsylvania, United States
#24 - Toxicity-Associated Discontinuations of Dolutegravir-and Bictegravir-Based Antiretroviral Treatment Regimens in Females Compared to Males: A Systematic Review and Meta-Analysis
Zhou Fang, Canada
#25 - Accumulating Safety Data for Antiretroviral Therapy In Pregnancy: Increasing reporting to the Antiretroviral Pregnancy Registry
Sushena Krishnaswamy, Australia
#75 - Socio-Economic Inequalities in the Coverage of Cervical Cancer Screening Among Women Living With HIV and Those Not Living With HIV in Five Sub-Saharan African Countries
Derrick Bary Abila, Uganda
#97 - Distribution of Vaccine-preventable HR-HPV Genotypes and Association with Cervical Cytology Patterns among Women Living with HIV at Kenya’s Referral Hospital
James Kangethe, Kenya
Saturday, 13 April
Session 4: Pregnancy and Breastfeeding -
Chairs
Angelina Namiba, BA Hons
4MNetwork of Mentor Mothers, United Kingdom
Annette Haberl, MD 
Hospital of the Johann Wolfgang Goethe-University Frankfurt, Germany
08:30
Infant Feeding Choices for Parents Living With HIV: Updates From the INFORM+ Forum Group
Natasha Davies, MD
Anova Health Institute, South Africa
8:50
Update on Use of Antiretrovirals in Pregnancy
Angela Colbers, PhD
Radboudumc, the Netherlands
09:10
#4 - Case Series of Women With HIV Who Breastfed
William Short
United States
09:25
#5 - Risk Factors for Preterm Birth in Pregnant Women Living With HIV: A 25-Year Analysis of the British Columbia Perinatal HIV Database
Jeffrey Man Hay Wong
Canada
09:40
#6 - Birth Defects Following Dolutegravir Transition among Women Delivering at Surveillance Sites in Eswatini
Philisiwe Ntombenhle Khumalo
Swaziland
9:55
#7 - The Health Outcomes Around Pregnancy and Exposure to HIV/ARVs (HOPE) Study: A Prospective Cohort of Reproductive-Aged Women Living With HIV
Deborah Kacanek
United States
10:10
Panel Discussion: Experience from Women Living with HIV (Breastfeeding) and Caregivers
10:30
Coffee Break
Session 5: Where Do We Stand: Women Aging with HIV - from Research to Service Delivery -
Chairs
Lena Serghides, PhD
University Health Network, Canada
Margaret Johnson, MD, FRCP
Royal Free London NHS Foundation Trust, United Kingdom
11:00
Participation of Women in Clinical Trials (Incl. Sex Differences in Efficacy and Safety Outcomes)
Kimberly Struble, PharmD
Food and Drug Administration, United States
11:20
Service Delivery for Women Aging with HIV
Luxey Sirisegaram, MD
University Health Network and Sinai Health Systems from University of Toronto, Canada
11:40
Cardiovascular Risk for Women - Data from the Reprieve Study
Sara E. Looby, PhD, ANP-BC, FAAN
Harvard Medical School / Massachusetts General Hospital, United States
12:00
Overview of Cardiovascular Diseases in Women
12:20
#8 - The CD38-NAD+ Axis Mediates a Hyperinflammatory State in WLWH
Poonam Mathur
United States
12:35
#9 - Sex Disparities in Geriatric Syndromes among People 50 Years or Older Receiving Care For HIV Infection in Mexico (2012-2017)
Yanink Caro-Vega
Mexico
12:50
Q&A
13:05
Lunch Break
Session 6: Abstract-Driven Presentations: Strategies for Prevention -
Chairs
Angelina Namiba, BA Hons
4MNetwork of Mentor Mothers, United Kingdom
Claudia Cortes, MD
University of Chile, Chile
14:05
#10 - Antiretroviral Therapy Adherence Strategies for Women with HIV in the Postpartum Period
Florence Momplaisir
United States
14:20
#11 - EmpowerHER: Black Women's Reasons for HIV Prevention
Dana Williams
United States
14:35
#12 - HIV Sero-Conversions Among Adolescent Girl and Young Female Dapivirine Vaginal Ring (DPV-R) Users: Early Learnings From a Demonstration Project in Zimbabwe
Jabulani Mavudze
Zimbabwe
14:50
#13 - Factors Associated with Unawareness of HIV Status and Recency of HIV Infections among Women Living with HIV: Findings from a Population-Based Survey in Thirteen African Countries
Irene Mbabazi
Uganda
15:05
Q&A
Session 7: Comorbidities and Women -
Chairs
Mona Loutfy, MD, FRCPC, MPH
Women's College Research Institute (Univ. Toronto), Canada
Fungai Murau, MCIM, MA
Independent Consultant (HIV), United Kingdom
15:20
Appropriate Use of Hormonal Replacement Therapy During Menopause
Karoline Aebi-Popp, PD, MD, MSc
University Hospital Bern, Switzerland
15:40
Metabolic Complications - The Role of the New Weight Reduction Therapies
Todd Brown, MD, PhD
Johns Hopkins University, United States
16:00
Comorbidities in Trans Women
Kate Nambiar, MD, PhD
Terrence Higgins Trust, United Kingdom
16:20
Q&A
16:35
Closing Remarks
Sharon Walmsley, CM, MD, FRCPC
University Health Network, Canada
Fungai Murau, MCIM, MA
Independent Consultant (HIV), United Kingdom
16:40
End of Workshop
Registration

Registration on-demand is now open!

Please note that payment by credit card is required to be able to register for the workshop. Please contact the conference secretariat if this is not possible for you.

Fees and Conditions

Regular Delegates-
In-Person

Regular Delegates-
Virtual

Industry* - In-Person

Industry* - Virtual

Early Fee (payment on/before 30 September 2023) 

$595.00

$475.00

$835.00

$715.00

Regular Fee (payment on/before 31 March 2024)

$835.00

$715.00

$1075.00

$955.00

Onsite/Same Day Fee (payment from 1 April 2024) 

$955.00

$835.00

$1195.00

$1075.00

Discounts

Early-Career Investigators and/or Academia from Resource-Limited Settings (RLS)** WITH an accepted abstract

100% Discount 

Early-Career Investigators and/or Academia from Resource-Limited Settings (RLS)** WITHOUT an accepted abstract, NGO Representatives/ Government Representatives (i.e. NIH, NIAID, CDC, etc) / Community Advocates

50% Off Current Academia Fee

Academia from High-Income Countries*** WITH an accepted abstract

Early Academia Fee

Representatives of Sponsoring Industry / Endorsing Organizations

Contact the Secretariat

People Living with HIV

100% Discount

* Industry representatives may receive a discount based on the level of support provided to the event. For more support and registration information, please contact us via Lara@amededu.com.

** Countries included in the low-income and lower middle-income economies of the World Bank Classification.

If you have financial concerns or are eligible for a discount, please contact the workshop secretariat via christina.moustakaki@amededu.com

Important
  • We strongly advise that you register early to ensure your registration. Registration will close when the capacity of the venue is reached.

  • Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.

Registration Fee Includes
For Onsite Attendees:

- Access to all scientific sessions, including poster area

- Workshop pack, including abstract book and program

- Refreshments during the coffee breaks

- Buffet lunch on meeting days

For Virtual Attendees Only:

- Access to all scientific sessions

- Digital workshop pack, including the program book

IMPORTANT:

- No day rate is available

- Payment can only be made by credit card.

- Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
Group Registration
For registration of groups larger than 5 participants, please use the Group Registration Portal.
Early-Career Investigators / Academia from Resource-limited Settings (RLS)
We are pleased to offer 100% registration fee waivers to early-career investigators and academia from low-income and lower-middle-income countries with an accepted abstract, and a 50% discount on the registration fee without an accepted abstract.

IMPORTANT: Registration fees waivers are offered to the presenting author only.

To be eligible as an early-career investigator, you should either be a current Master/PhD student or have obtained an MD/PharmD/PhD degree in the last five years. An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least two weeks prior to the start of the workshop. Virology Education will contact the early-career investigator with instructions regarding the registration procedure.
Payment
By credit card only: online or by written authorization (see online registration).
Cancellation Policy
In case of cancellation, the following refunds are applicable:

- Cancellation before/on 12 March 2024: 50% refund (minus an administration fee of $40)

- Cancellation after 12 March 2024: Unfortunately, no refund will be given

If you are unable to attend the conference, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 29 March 2024. A statement (email/letter) of cancellation must be sent to Virology Education.
Liability and Insurance
By registering for the workshop, participants agree that the organizers do not accept responsibility for medical, travel, or personal insurance. Participants are advised to take out their own insurance policies.
Media Registration
In order to register as a media participant for the workshop, the workshop secretariat needs to receive:

1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop

A free or reduced registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.

We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@amededu.com.

Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2020 embargo policy.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The organizing secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop. In case of cancellation of the meeting due to unforeseen circumstances, Virology Education cannot be held responsible for expenses made for travel, accommodation, visa applications, etc.
Abstracts

Abstract Submission Portal is now closed.

Abstract Submission Deadline: Friday, 19 January 2024 at 23:59 EST
Abstracts
  • HIV & Women 2024 accepts new original as well as encored abstracts. All abstracts must focus on HIV & Women and contain up-to-date information at the time of the workshop. 
  • Complimentary registration is given to healthcare professionals from Resource-Limited Settings and Early-Career Investigators with an accepted abstract. A 50% discount is offered to Early-Career Investigators without an accepted abstract. The requirements for the application are specified under "Registration". 

  • Abstract submitters are strongly encouraged to use person-first language in their abstracts. View our guidelines here

  • Abstract presenters are expected to attend the workshop in-person to present their abstract. Please contact the workshop secretariat if this is not possible.

Terms and Conditions

By submitting an abstract to a meeting organized by Virology Education BV (VE), the abstract submitter hereby agrees to the terms and conditions.

The terms and conditions can be viewed here.  

Categories for Abstract Submission
For purposes of review and programming, abstracts are divided into topical categories. The selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.

· Epidemiology of HIV and STIs in Women

· Strategies Towards the End of AIDS

· HIV Prevention in Women (Including PrEP and U=U)

· Diagnosis, Treatment, and Models of Care of HIV Infection for Women

. Contraception

. Pregnancy and Vertical Transmission

. Breastfeeding

. ART Choices and Toxicity for Women

. Co-Morbidities and Aging in Women Living With HIV

. Priority Female Populations: Adolescents, Transgender Women, Sex Workers, People Who Inject Drugs, People Living Within Closed Systems, and other Incarcerated Women (UNAIDS Guidelines)

. Challenges for Women Living With HIV: Mental Health, Poverty, Trauma

. Emerging Infections

. Other Research Relevant to HIV and Women
General Guidelines
Abstracts should contain the following four components:

- Background: A concise statement of the issue under investigation or a hypothesis;

- Material and Methods: The experimental methods used (including the statistical analyses employed);

- Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);

- Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.

We strongly encourage you to use person-first language in your abstract(s). View our guidelines: https://academicmedicaleducation.com/person-first-language
Abstract Submission
Authors can submit their abstracts electronically until 19 January 2024. You will be redirected to the submission website. Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.
Poster Presentation Instructions
Note: For hybrid events, poster presenters are expected to attend onsite.
Posters need to meet the following dimensions: approx. 33" x 44" in portrait format.
Please display the number of your poster in the upper right corner of your poster.
In addition, you are welcome to make a short recording (max. 2 min) of your presentation with a few slides using PowerPoint. You can record this video directly from PowerPoint.
Your poster and the short video will be available on our website after the workshop days.
Once onsite:
Poster presenters are requested to stand near their posters during the poster session.
We advise you to prepare hand-outs of your poster on Letter or A4 format.
Please hang your posters as early as possible. All posters must be displayed from the opening session to the closure of the meeting.
Pushpins and/or velcro will be provided.
Committees
Organizing Committee

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

Scientific Committee

The members of the Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

  • Karoline Aebi-Popp, PD, MD, MSc, University Hospital Bern, Switzerland
  • Sergii Antoniak, MD, Gromashevsky Institute of Epidemiology and Infectious Diseases, National Academy of Medical Sciences of Ukraine, Ukraine
  • Dawn Averitt, The Well Project/WRI, United States
  • Olga Belyaeva, Eurasian Network of People who Use Drugs (ENPUD), Ukraine
  • Marina Bobkova, MD, PhD, Gamaleya Center for Epidemiology and Microbiology, Russian Ministry of Health, Russia                     
  • Claudia Cortes, MD, University of Chile, Chile
  • Dazon Dixon Diallo, MPH, Sister Love, United States
  • Mirjam-Colette Kempf, MD, MPH, University of Alabama at Birmingham, United States
  • Justyna Kowalska, MD, PhD, Hospital for Infectious Diseases, Poland
  • Allen Kyendikuwa, BA, Uganda Youth Coalition on Adolescent SRHR and HIV (CYSRA), Uganda
  • Mona Loutfy, MD, FRCPC, MPH, Women's College Research Institute (Univ. Toronto), Canada
  • Mariana Mardarescu, MD, PhD, National Institute for Infectious Diseases "Prof. Dr. Matei Bals", Romania
  • Catia Marzolini, PharmD, PhD, University Hospital Basel, Switzerland
  • Deborah Money, MD, FRCSC, University of British Columbia, Canada
  • Teresia Otieno, ATHENA Network, United States
  • Lena Serghides, PhD, University Health Network, Canada
  • William R. Short, MD, MPH, FIDSA, University of Pennsylvania, United States
  • Shema Tariq, PhD, FRCP, University College London, United Kingdom
  • Patricia Vasquez, MD, Hospital San Juan de Dios, Chile
  • Marta Vasylyev, MD, Astar Medical Center, Ukraine
  • Markella Zanni, MD, MGH/Harvard Medical School, United States
Support
Scholarships Supporter
Support Our Initiative

Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals, researchers, and community representatives involved in the International Workshop on HIV & Women 2024.
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
 
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Ms. Lara da Silva Miguel at Lara@amededu.com.
 
Benefits of Support 
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

  • Symposium opportunities
  • Non-commercial interviews with company representatives
  • Verbal acknowledgment during the program 
  • Discounted and complimentary registrations for your representatives
  • Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
  • Company acknowledgment on printed meeting materials including but not limited to banners and the program book
  • Digital and printed advertising opportunities 
  • Social media shout-outs
  • Logo on the conference bag 

 
*Subject to the support level

Endorsers
Accommodation
We look forward to welcoming you to Washington DC!

As you plan your trip to Washington DC, we want to make your stay is as comfortable and convenient as possible. Therefore, we are pleased to offer to all participants of HIV & Women 2024 a selection of accommodation options depending on your preferences and budget.

To benefit from a special discount on the best available rates, please book your accommodation through the following reservation links.

Reservation Links
Mayflower
The Mayflower Hotel
Expiration date: 21 March 2024
Marriott
Washington Marriott at Metro Center
Expiration date: 21 March 2024
Motto by Hilton Washington DC City Center
Motto by Hilton Washington DC City Center
Expiration date: 12 March 2024
capital hilton
Capital Hilton
Expiration date: 12 March 2024
Westin
The Westin Washington, D.C. City Center
Expiration date: 21 March 2024
Scholarships

Scholarship Application Portal is now closed.

Scholarship Application Deadline: 26 January 2024
Scholarships

Virology Education (VE), with support from the industry, is offering scholarships to attend HIV & Women 2024. Depending on the type of scholarship awarded, the scholarship covers registration and/or travel and accommodation. 

The scholarships are supported by industry. These companies will have no control, influence, or involvement in selection of any attendees.

Virology Education is proud to support participation from professionals from underrepresented communities. We strongly recognize the value of conducting our programs with a diverse and inclusive representation of the scientific and medical global community, welcoming a range of backgrounds, experiences, and opinions and embracing the benefits that these differences bring. This diversity and equity are essential to our mission of advancing clinical care and scientific research worldwide.

Read our Code of Conduct

What does the Scholarship Cover?
  • Registration Scholarship: 

  • Registration only
  • Partial Scholarship:

  • Registration
  • Accommodation
  • Full Scholarship:

  • Registration
  • Accommodation
  • Travel
What is Expected from the Scholarship Recipents?

All scholarship awardees are required to attend the full meeting. Awardees must sign in at the beginning of each meeting day and sign off at the end of each day as requested by the Conference Organizer. At the close of the Workshop, awardees must have completed the daily and overall workshop evaluations.

Recipient will provide post-meeting feedback and a summary about his/her workshop experience within one month after the end of the workshop. The feedback questionnaire will be an online survey with the recipient providing feedback on their experience at the workshop, scholarship procedure, and how they will implement the knowledge acquired at the meeting in their daily practice. The questionnaire will be sent to each recipient by email within one week after the conclusion of the workshop.

Eligibility

Applicants must:

  • Be proficient in english to interact with faculty and fellow attendees
  • Be actively involved in the field of HIV & Women
  • Be able to show benefits to their patients / research / community from attending the meeting
  • Be willing and able to share information learned at the meeting with a larger community
  • Be eligible to obtain a visa for travel. Declare that she/he is able and willing to fund all other costs beyond the scholarship that are involved in attending the workshop, e.g. all other hotel, travel and subsistence expenses NOT covered by the scholarship.
  • Declare to take out her/his own insurance policies (for travel, liability, illness and/or other necessary insurances in relation to her/his participation to the conference).
  • Conference organizer will automatically decline all scholarship applications that do not conform to the eligibility terms
Application Procedure

The scholarship applications must be submitted online through our Scholarship Application Portal. The applicant will be asked to submit a motivational letter (min. 100 words) describing how their patients/research/community will benefit from the knowledge gained at these meetings, and their knowledge dissemination strategy, a CV, and a letter of recommendation (optional).

  • All applications will be acknowledged upon receipt.
  • All applications will be reviewed by an independent Scholarship Review Committee
  • Successful applicants will be sent a scholarship agreement.
  • After receipt of the signed scholarship agreement, successful applicants will receive instructions for travel arrangements.
  • All applicants will receive notification of the application status no later than 1 month prior to the meeting they are planning to attend.
Selection Criteria
  • Professional background
  • Quality of the abstract (if accepted)
  • Country of residence
  • Recommendation by your supervisor
  • Demonstrable benefits to patients / research / community by the knowledge to be gained at this meeting
  • Strategy of knowledge dissemination
  • Early-Career Investigator
Important
  • Incomplete applications will not be considered. Conference Organizer cannot be held responsible for any incorrect information that is submitted through the scholarship application portal.
  • All travel arrangements will be made by Conference Organizer in collaboration with their preferred business travel partner. Conference Organizer cannot reimburse any travel costs made by participants themselves.
  • Retrospective applications will not be considered.
  • Scholarship recipients must attend the entire conferences.
  • Scholarship recipients are committed to attend the meetings in person. If they fail to do so, they will be charged the full amount of the travel and accommodation costs incurred and will be excluded from applications for future scholarships of Conference Organizer.
  • Scholarships are non-transferrable.
  • Conference Organizer cannot guarantee awarding the scholarship to prospective scholarship recipients until the confirmation of available funds. In the event that sufficient funding for the scholarship is not available, Conference Organizer will not be liable for any expenses or damages incurred by the prospective scholarship recipient with regards to the scholarship application and/or preparation for the meeting.
  • Applications will be considered until the exhaustion of funds.
  • Scholarship recipients will be responsible for all other costs associated with conference attendance.
  • Conference Organizer will not be liable for any injury, death, damage, loss, delay, cost, expense, or inconvenience, causes of action claims and suits for property damage, theft of property or personal injury (including death) arising in connection with the scholarship and participation in the Conference.
  • Conference Organizer reserves the right to make the final decision regarding all applications, which cannot be disputed.
Photo Gallery
Group Photo
 
Group photo - HIV & Women 2024

Previous Editions
Language
Ratings previous edition
I would recommend this workshop to my peers
4.8
(113)
Content was presented clearly
4.5
Content is relevant to my practice
4.5